PS
Pushpendra Singh
About Pushpendra Singh
Data last updated:
Pushpendra Singh is a Director at Kovial Biotech Private Limited (since 2021), Director at Astrofine Pharma Private Limited (since 2021) and Director at Sunfine Healthcare Private Limited (since 2022). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹5.13 Cr; the largest is Kovial Biotech Private Limited at ₹3.43 Cr (FY 2025). Earlier, Pushpendra Singh was a Director at Siraigo Pharma Private Limited (2016–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kovial Biotech Private Limited U24100HP2021PTC008643 | Director | 25 Jun 2021 | 2021 | ₹3.43 Cr (FY 2025) | Active |
| Astrofine Pharma Private Limited U24290HP2021PTC008952 | Director | 10 Nov 2021 | 2021 | ₹1.70 Cr (FY 2024) | Active |
| Sunfine Healthcare Private Limited U24290HP2022PTC009153 | Director | 21 Feb 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Siraigo Pharma Private Limited U24230MH2004PTC146558 | Director | 04 Mar 2016 | 2004 | ₹2.00 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Pushpendra Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Gayatri Devi | 11082303 | Kovial Biotech Private Limited | Director |
| Vishav Nath Jindal | 09326445 | Astrofine Pharma Private Limited | Director |
| Parvindra Kumar | 09216450 | Sunfine Healthcare Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pushpendra Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pushpendra Singh
Pushpendra Singh currently holds 3 directorships: Kovial Biotech Private Limited (Director, since 25 Jun 2021, revenue ₹3.43 Cr (FY 2025)); Astrofine Pharma Private Limited (Director, since 10 Nov 2021, revenue ₹1.70 Cr (FY 2024)); Sunfine Healthcare Private Limited (Director, since 21 Feb 2022).
Pushpendra Singh was first appointed on 04 Mar 2016 as Director at Siraigo Pharma Private Limited. The most recent appointment on record is 21 Feb 2022 at Sunfine Healthcare Private Limited.
The 2 current companies of Pushpendra Singh that report revenue have a combined latest revenue of ₹5.13 Cr: Kovial Biotech Private Limited ₹3.43 Cr (FY 2025); Astrofine Pharma Private Limited ₹1.70 Cr (FY 2024).
Pushpendra Singh held 1 earlier board appointment: Siraigo Pharma Private Limited (Director, 04 Mar 2016 to 02 Aug 2017).
The current boards of Pushpendra Singh's companies include Gayatri Devi (Kovial Biotech Private Limited), Vishav Nath Jindal (Astrofine Pharma Private Limited), Parvindra Kumar (Sunfine Healthcare Private Limited).